Sickle Cell Disease Conference for the People 2022

855 S F Street,Oxnard CA 93030

19 March, 2022

Description

Sickle Cell Disease Conference for the People 2022 “To increase the quality of life for individuals diagnosed with sickle cell disease in California by ensuring expert, unbiased, and comprehensive care.” This mission is part of a broader vision of (1) a medical system which effectively addresses the unique needs of individuals with sickle cell disease and (2) patients who are empowered and equipped to advocate for themselves. Sickle Cell Disease Conference for the People intends to: - Educate on the pathophysiology, complications, management, and FDA approved treatments for sickle cell disease; and - Increase the knowledge of the audience on sickle cell disease and trait. OUR SPONSOR: GBT is determined to be a catalyst for change and committed to improving the care of people living with sickle cell disease. Driven by a sense of urgency to address long-standing lack of innovation, GBT is changing the way treatments are developed and delivered. We are collaborating with the sickle cell community, including healthcare professionals, patient advocacy groups and community-based organizations, to increase awareness of sickle cell disease (SCD) and how it affects patients. We are working to change the treatment paradigm in this disease, while helping the sickle cell community advocate for quality care. GBT is committed to helping people with SCD gain broad access to our therapies, once approved by regulatory authorities, and to remove other barriers to care. We do this, in part, by working with government agencies, including the U.S. Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS), and policymakers to develop breakthroughs in SCD treatment and enable broader access to care. We also provide funding support for the U.S. Centers for Disease Control and Prevention’s Sickle Cell Data Collection Program, which collects health information about people with SCD to study long-term trends in diagnosis, treatment and access to healthcare. For more information, please visit www.gbt.com.